Therapeutic Drug Monitoring Market Size, Share, Growth, Trends and Industry Analysis Report
by Susan Hill Business ConsultantThe global therapeutic drug monitoring market is expected to
reach over USD 3.37 billion by 2024, according to a new report by Grand View
Research, Inc. Recent technological advancements in the Point-of-Care (PoC)
devices hold considerable transformative promises for the personalized
predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a
foundational part to the devising of personalized treatment plans for patients;
and the advent of PoC diagnostic devices that yield quantitative measurements
of the drug concentration plays a pivotal role in supporting the development of
the precision medicine field in the healthcare sector. However, the broad
application of the PoC devices for patient monitoring is still lagging behind.
The presence of this untapped opportunity is one of the high impact rendering
drivers for the market growth.
The employment of continuous
therapeutic drug and metabolite monitoring in the early phase of the medication
regimen, administered post-organ transplantation, forms a major application in
the areas of critical care medicine and organ transplantation, which is
expected to propel the growth of the therapeutic drug monitoring market over
the forecast period. In addition, the imposing burden of diseases, such as
epilepsy and cancer, the rising government initiatives, and the presence of
high-unmet needs are some of the crucial determinants expected to further favor
the emergence of this market.
Further key findings from the study suggest:
- The consumables segment covered over 65%
of the market share in 2015 as a consequence of the extensive requirement
of the consumables in the research laboratories and due to the repeat
purchase of the kits and reagents.
- The immunoassay segment held the largest
market share in 2015. The presence of several commercially available immunoassays
combined with their associated benefits including the cost effectiveness
and easy-to-handle nature of the products are the key drivers for the
growth of this segment.
- The proteomics
category is expected to be the fastest growing technology segment due to
the advent of various proteomic technologies, such as isotope-coded
affinity tags, next generation sequencing, and protein microarray
platforms that enable rapid mining of the proteome.
- The hospital is the largest end-use
segment with a share of over 60% in 2015. In larger hospitals, various
underlying technologies are employed to perform immunoassays; these
comprise chemiluminescence, nephelometry, colorimetry, and fluorescence,
which are available for the testing of a wide-ranging drug panel.
- The drug monitoring for the
immunosuppressants is one of the fastest growing application segments
owing to the introduction of novel TDM point-of-care testing devices for
the evaluation of the concentration of administered immunosuppressants and
the complementary metabolites, in order to achieve a prominent therapeutic
effect while preventing drug toxicity events in patients that have
undergone transplantations.
- In 2015, North America was the highest
revenue generating region with revenue generated over USD 900 million. The
rising number of R&D activities coupled with the high awareness about
personalized therapy is the major determining factor for the large share
captured by the North America region.
- Few of the leading market players are
Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific,
Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott
Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and
Alere, Inc. The persistent R&D efforts are being undertaken along with
numerous other strategic endeavors being adopted by the market players
with the objective of enhancing the present drug monitoring practices and
to develop novel technologies.
Access full research report on global therapeutic
drug monitoring market:
www.grandviewresearch.com/industry-analysis/therapeutic-drug-monitoring-market
Sponsor Ads
Created on Apr 8th 2020 10:51. Viewed 305 times.